Vytorin Continues to Break Hearts at Merck, Schering
July 22, 2008 by MedHeadlines
Filed under Cholesterol, Drugs, Heart Disease, Medical Research
The bad news just seems to keep coming. The results of the latest test of the prescription drug, Vytorin, show the drug produced no significant indication that it is effective in the treatment of aortic valve disease and heart disease. The test also showed that Vytorin actually increased the number of heart events deemed “serious” when cancer patients take the drug. Read more
Loading ...
